Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve This is to intimate ....
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed BSE and NSE about a Board Meeting scheduled for Friday, 30th May, 2025. The main agenda is to consider and approve the Audited Financial Statements for the quarter and year ended 31st March, 2025 (Q4 and FY25 results). Any other business may be taken up with the Chair's consent. As per insider trading rules, the trading window for the company's shares will remain closed until 48 hours after the board meeting concludes.
This is a routine pre-results intimation — no actual financial numbers are disclosed yet. Investors should watch for the FY25 audited results on/after 30th May, 2025, which will reveal the company's full-year performance, profitability, and any auditor observations.